Gilead Sciences

Senior Manager, Medical Writing

United States

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in Medical Writing, Scientific Writing, Biology, or a related scientific field, and have at least 8 years of experience in medical writing, with a minimum of 5 years in the pharmaceutical or biotechnology industry. Strong knowledge of regulatory requirements for drug development, including FDA guidelines and ICH guidelines, is essential. Demonstrated experience in authoring and reviewing complex regulatory documents, such as clinical study reports, investigator’s brochures, and regulatory submissions, is required. Excellent writing, editing, and communication skills are necessary, along with the ability to work independently and as part of a team.

Responsibilities

The Senior Manager, Medical Writing will author a wide variety of documents of all types and complexities, such as clinical study reports (CSRs all phases), investigator’s brochures, CTD summaries/overviews, PIPs/PIP modifications, and regulatory responses. They will represent Medical Writing in cross-functional teams, such as product, project and/or regulatory submissions teams; providing guidance for optimal presentation of data to achieve document intent. They will plan and oversee assigned medical writing deliverables, including development and management of document timelines and resource planning for assigned projects. They may serve as the filing lead for small to medium regulatory submissions and may serve as lead medical writer and department representative across development programs. The role involves participating in the development/improvement of document standards, templates, and processes, and may also involve coaching, training, and providing guidance to less experienced Medical Writing colleagues. They will manage or supervise contractors to ensure the highest quality of medical writing and adherence to Gilead documents standards.

Skills

Medical Writing
Regulatory Content
Scientific Communication
Cross-functional Collaboration
Drug Development
Regulatory Submissions

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Key Metrics

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI